UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of
May 2019
Commission File Number:
001-36187
EVOGENE LTD.
(Translation of Registrant’s Name into English)
13 Gad Feinstein Street
Park Rehovot P.O.B 2100
Rehovot 7612002 Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
CONTENTS
The 2019 annual general meeting of shareholders (the “
Meeting
”) of Evogene Ltd. (“
Evogene
”) will be held at Evogene’s offices, located at 13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel, on Wednesday, June 26, 2019 at 3:00 p.m., Israel time. In connection with the Meeting, Evogene hereby furnishes the following documents:
|
Exhibit 99.1
|
Notice of the Meeting.
|
|
Exhibit 99.2
Exhibit 99.3
|
Proxy Statement for the Meeting.
Form of Proxy Card for the Meeting.
|
The foregoing exhibits are also available at Evogene’s website, at http://www.evogene.com/investor-relations/.
The contents of, and exhibits to, this Form 6-K are hereby incorporated by reference into Evogene’s registration statements on Form S-8 (File No’s. 333-193788, 333-201443 and 333-203856).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Date: May 14, 2019
|
|
EVOGENE LTD.
(Registrant)
By:
/s/ Dorit Kreiner
Name: Dorit Kreiner
Title: Chief Financial Officer
|
EXHIBIT INDEX